Table 3. Cox regression examination investigating the impact of clinicopathological variables on patients’ overall survival.
Variables | Univariable Cox regression | Multivariable Cox regression | |||
---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
Gender (male) | 0.689 (0.361–1.313) | 0.69 | |||
Age | 0.998 (0.976–1.021) | 0.88 | |||
Smoking | 1.834 (1.120–3.002) | <0.001 | 2.945 (1.858–4.667) | <0.001 | |
Tumor volume | 1.003 (1.002–1.004) | <0.001 | 1.003 (1.002–1.004) | <0.001 | |
Tumor differentiation (Low) | 6.453 (3.974–10.477) | <0.001 | 4.285 (2.553–7.191) | <0.001 | |
Gene mutation | 0.170 (0.077–0.372) | <0.001 | 0.208 (0.094–0.463) | <0.001 | |
Complication | 1.618 (1.062–2.466) | 0.03 | 1.156 (0.756–1.766) | 0.50 | |
Neutrophil | 1.315 (1.145–1.510) | <0.001 | 1.287 (1.157–1.432) | <0.001 | |
Monocyte | 1.181 (0.273–5.104) | 0.82 | |||
Lymphocyte | 0.590 (0.410–0.849) | 0.004 | 0.447 (0.308–0.650) | <0.001 | |
Platelet | 1.001 (0.998–1.004) | 0.55 |
HR, hazard ratio; CI, confidence interval.